digital currency exchange rates, Top

Syrian opposition forces claimed to have taken control of the eastern Syrian city of Deir ez-Zor. According to Al Jazeera and Arabiya TV, on the 10th local time, Hassan Abdel Ghani, commander of Syrian opposition forces, said that "the eastern Syrian city of Deir ez-Zor has been completely controlled".Fenda Technology's daily limit today was 110 million yuan, and Fenda Technology's daily limit today was 6.402 billion yuan, with a turnover rate of 42.27%. After-hours data showed that the special seats of Shenzhen Stock Connect bought 104 million yuan and sold 118 million yuan, and the special seats of the two institutions sold 110 million yuan.Qujiang Wenlv: It received a warning letter from Shaanxi Supervision Bureau, and Qujiang Wenlv announced that the company received the Decision on Taking Measures to Issue Warning Letters to Xi 'an Qujiang Cultural Tourism Co., Ltd., Xie Xiaoning and Xi 'an Qujiang Tourism Investment Co., Ltd. issued by Shaanxi Supervision Bureau of China Securities Regulatory Commission on December 10, 2024. After investigation, the company delayed the disclosure of the major event that 8.23% of the company's shares held by the controlling shareholder Xi 'an Qujiang Tourism Investment Co., Ltd. were to be disposed of by the judiciary, which violated the relevant provisions of the Measures for the Administration of Information Disclosure of Listed Companies. According to Article 52 of the Measures, Shaanxi Supervision Bureau decided to take administrative supervision measures to issue warning letters to the company, Xie Xiaoning, the relevant responsible person, and Qujiang Travel Investment, the controlling shareholder. The company will seriously rectify, strengthen information disclosure and corporate governance, and improve the operation level and information disclosure quality.

Japanese Reuters's short-term non-manufacturing boom judgment index in December is 30, with the previous value of 19; Reuters's short-term judgment index of manufacturing prosperity in December was -1, with the previous value of 5.Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.Oppenheimer: Raise the target price of opening customers from $980 to $1,075, and reiterate the rating of "outperforming the market".

 Oppenheimer: Raise the target price of opening customers from $980 to $1,075, and reiterate the rating of "outperforming the market".Jiayi Co., Ltd.: It plans to increase capital by 28 million US dollars to set up Vietnam Sun Company. Jiayi Co., Ltd. announced that the company plans to increase capital by 28 million US dollars to its wholly-owned subsidiary Jiayi Singapore with its own funds for the establishment of wholly-owned Sun Company Jiayi Drinking Water Co., Ltd. in Vietnam. This investment aims at expanding overseas production bases, enhancing supply chain flexibility, enhancing core competitiveness and accelerating business internationalization.